Qube Research & Technologies Ltd
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,348,774
-$3,950,539 QoQ
Shares Held
187,667
-50.4% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,034,188,909 across 187 Biotechnology names. AGIO ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in AGIO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,348,774 | 187,667 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,299,313 | 378,373 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $2,241,025 | 67,379 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,749,814 | 127,980 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,571,014 | 199,970 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,750,647 | 84,417 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,070,669 | 24,830 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,264,454 | 43,244 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,616,992 | 117,512 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $1,096,832 | 39,061 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,880,038 | 84,801 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,032,415 | 35,466 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,125,501 | 34,241 | Shares | Sole | 2022-02-10 | |
| 2020-09-30 | $608,475 | 17,385 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $461,559 | 13,009 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||